ICMB
Investcorp Credit Management BDC, Inc.
There isn't enough reported data to score ICMB yet.
JPM
JPMorgan Chase & Co.
JPM's fundamentals are strong, but it looks expensive: trading at 14x earnings, above its usual 12x. Analysts expect earnings growth.
ICMB Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| N/A | |
| N/A |
ICMB's profitability is currently weak. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like ICMB.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
ICMB PE Valuation
ICMB has no meaningful PE right now: it lost money over the past year.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
ICMB Forward outlook
There aren't enough analyst estimates for ICMB to show an outlook.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
ICMB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.65 | -$1.64 |
| Q2 2026 | -$1.41 | -361% |
| Q1 2026 | -$1.36 | -409% |
| Q4 2025 | -$0.61 | -233% |
| Q3 2025 | -$0.01 | -103% |
| Q2 2025 | $0.54 | +$0.82 |
| Q1 2025 | $0.44 | +$0.45 |
| Q4 2024 | $0.46 | +$0.72 |
ICMB lost $1.65 per share over the past year, and its loss has widened in each of the last five quarters.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over ICMB on earnings quality, reporting a profit while its opponent remains loss making.
ICMB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2022 | $6.8M | +9.2% |
| Q3 2022 | $6.3M | -2.8% |
| Q2 2022 | $5.8M | -12% |
| Q1 2022 | $5.9M | -1.6% |
| Q4 2021 | $6.2M | -12% |
| Q3 2021 | $6.5M | -7% |
| Q2 2021 | $6.6M | -13% |
| Q1 2021 | $6M | -32% |
JPM has the stronger quarterly revenue trend. Revenue is down 88% for ICMB versus up 8.1% for JPM.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2024 | 222% | N/A |
| Q4 2022 | 70% | +4.1 points |
| Q3 2022 | 69% | +1.6 points |
| Q2 2022 | 73% | +8.8 points |
| Q1 2022 | 64% | -0.2 points |
| Q4 2021 | 66% | -2.4 points |
| Q3 2021 | 68% | -0.1 points |
| Q2 2021 | 64% | -2.3 points |
ICMB's operating margin was 222% last quarter, up 159 points from the same quarter a year ago, near the top of its range since 2019.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM's operating margin was 40% last quarter, about level with the same quarter a year ago.
ICMB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.9M | +125% |
| Q2 2026 | $9.3M | +$16M |
| Q1 2026 | $10.8M | +113% |
| Q4 2025 | $12M | +$19.2M |
| Q3 2025 | $1.3M | +167% |
| Q2 2025 | -$6.7M | -161% |
| Q1 2025 | $5.1M | -63% |
| Q4 2024 | -$7.2M | -576% |
ICMB has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
ICMB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | 0% | +1.3K shares |
| 3 years | +0.3% | +39.8K shares |
| 5 years | +2.6% | +366K shares |
| Available history | +5.6% | +764K shares |
ICMB has 14M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over ICMB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
ICMB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2022 | 7.5x | High |
| Q3 2022 | 9.1x | High |
| Q2 2022 | 8.7x | High |
| Q1 2022 | 10.1x | High |
| Q4 2021 | 9.6x | High |
| Q3 2021 | 8.9x | High |
| Q2 2021 | 9.0x | High |
| Q1 2021 | 7.4x | High |
ICMB's net debt is about 7.5 years of its operating earnings (EBITDA), down from 9.6 years a year ago. Net leverage isn't a meaningful measure for financial services companies like ICMB.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
ICMB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.1 | Neutral |
| Stochastic | 41.8 | Neutral |
ICMB's weekly RSI is 50 (neutral) and its Stochastic is 42 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
ICMB PE vs Financial Services Sector
| Metric | ICMB | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
ICMB has no meaningful PE right now: it lost money over the past year.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
ICMB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.76 | 39% above |
| 20 week MA | $0.82 | 29% above |
| 50 week MA | $1.63 | 35% below |
| 100 week MA | $2.28 | 54% below |
| 200 week MA | $2.89 | 63% below |
ICMB has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 63% below its 200-week average.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over ICMB on trend strength, trading above more of its moving averages.
ICMB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.75 | $4.48 | -34% |
| 2021 | $4.48 | $4.86 | +8.5% |
| 2022 | $4.86 | $3.65 | -25% |
| 2023 | $3.65 | $3.56 | -2.5% |
| 2024 | $3.56 | $3.05 | -14% |
| 2025 | $3.05 | $2.70 | -11% |
| 2026 YTD | $2.70 | $1.06 | -61% |
ICMB has finished four years in a row lower, and it's down 61% so far in 2026.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over ICMB on returns for 2026, with the stronger performance.